Indian Institute of Toxicology Research, (Council of Scientific and Industrial Research, India), P.O. Box 80, M. G. Marg, Lucknow 226001, India.
J Biomed Nanotechnol. 2011 Feb;7(1):202. doi: 10.1166/jbn.2011.1268.
Anti-cancer potential of polymer based nanoparticle of EGCG and TF alone and in combination with anti-cancer drug cisplatin have been studied in human cancer lines: A549 (lung carcinoma), HeLa (cervical carcinoma) and THP-1 (acute monocytic leukemia) using cell proliferation assay and cell cycle analysis. Encapsulated polyphenols retained biological effectiveness with over 20-fold dose advantage than EGCG/TF in exerting anti-cancer effects and also enhanced the potential of a widely used anti-cancer drug cisplatin. Subsequently, encapsulated polyphenols alone or in combination with cisplatin were more effective in inhibiting cell proliferation, metastasis, angiogenesis and apoptosis biomarkers. Collectively, our observations reveal that nanoparticle-mediated delivery of phytochemicals could serve as a basis for enhancing bioavailability and limiting the unwanted toxicity of chemotherapeutic agents.
聚合物基 EGCG 和 TF 纳米粒子单独及与抗癌药物顺铂联合的抗癌潜力已在人癌细胞系 A549(肺癌)、HeLa(宫颈癌)和 THP-1(急性单核细胞白血病)中通过细胞增殖测定和细胞周期分析进行了研究。包封多酚在发挥抗癌作用方面比 EGCG/TF 具有超过 20 倍的剂量优势,并且还增强了广泛使用的抗癌药物顺铂的潜力。随后,包封多酚单独或与顺铂联合使用时,在抑制细胞增殖、转移、血管生成和凋亡生物标志物方面更有效。总之,我们的观察结果表明,基于纳米粒子的植物化学物质传递可以作为增强生物利用度和限制化疗药物不良毒性的基础。